Céleste Lebbé Selected Research

Céleste Lebbé Research Topics

Disease

68	Melanoma (Melanoma, Malignant) 04/2024 - 10/2009
39	Neoplasms (Cancer) 04/2024 - 04/2008
10	Neoplasm Metastasis (Metastasis) 11/2023 - 06/2010
8	Merkel Cell Carcinoma 01/2021 - 10/2016
5	Disease Progression 01/2021 - 10/2013
4	Carcinoma (Carcinomatosis) 11/2022 - 11/2014
4	Infections 01/2022 - 10/2005
4	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2019 - 04/2008
4	Colitis 10/2018 - 05/2015
3	Carcinogenesis 04/2024 - 10/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2016
3	Skin Neoplasms (Skin Cancer) 09/2021 - 04/2017
3	Sarcoidosis (Schaumann Disease) 05/2016 - 02/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 04/2008
2	Lymphatic Metastasis 09/2021 - 05/2015
2	Dermatofibrosarcoma 05/2021 - 02/2018
2	Hepatitis 03/2021 - 01/2018
2	Collagenous Colitis 07/2020 - 01/2016
2	Diarrhea 07/2020 - 01/2016
2	Fatigue 01/2020 - 10/2017
2	Body Weight (Weight, Body) 10/2019 - 11/2016
2	Sarcoma (Soft Tissue Sarcoma) 08/2019 - 02/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2018
2	Pain (Aches) 12/2018 - 10/2017
2	Insulin Resistance 01/2018 - 12/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Myocarditis (Carditis) 11/2017 - 05/2015
2	Synovitis 10/2017 - 10/2016
2	Brain Neoplasms (Brain Tumor) 01/2017 - 06/2010
2	Lipodystrophy 12/2007 - 10/2007
2	Viremia 03/2006 - 07/2002
1	Vascular Tissue Neoplasms 11/2022
1	HIV Infections (HIV Infection) 01/2022
1	Sepsis (Septicemia) 01/2021

Drug/Important Bio-Agent (IBA)

16	Immune Checkpoint InhibitorsIBA 06/2022 - 05/2016
14	IpilimumabIBA 10/2023 - 06/2010
14	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2023 - 12/2012
11	NivolumabIBA 10/2023 - 05/2016
7	avelumabIBA 01/2021 - 10/2016
6	pembrolizumabIBA 01/2021 - 01/2016
6	VemurafenibIBA 10/2017 - 10/2012
6	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2016 - 10/2009
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2016
5	Mitogen-Activated Protein KinasesIBA 12/2023 - 10/2008
5	Biomarkers (Surrogate Marker)IBA 05/2023 - 10/2009
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 02/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2009
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2024 - 01/2015
4	dabrafenibIBA 01/2020 - 12/2012
4	AntibodiesIBA 01/2018 - 10/2016
4	LigandsIBA 01/2018 - 01/2012
3	trametinibIBA 01/2017 - 12/2012
3	Monoclonal AntibodiesIBA 10/2016 - 12/2006
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2015 - 12/2009
3	Peptide Hydrolases (Proteases)FDA Link 01/2015 - 12/2009
2	IntegrinsIBA 04/2024 - 06/2015
2	Protein Isoforms (Isoforms)IBA 11/2022 - 12/2009
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 11/2022 - 09/2021
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2022 - 10/2017
2	Fluorescein-5-isothiocyanate (FITC)IBA 04/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2003
2	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 01/2021 - 01/2021
2	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 01/2020
2	Budesonide (Pulmicort)FDA LinkGeneric 07/2020 - 01/2016
2	Interleukin-2 (IL2)IBA 01/2018 - 10/2005
1	CollagenIBA 04/2024
1	Serine (L-Serine)FDA Link 01/2024
1	Phosphodiesterase 4 InhibitorsIBA 12/2023
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2023
1	Programmed Cell Death 1 ReceptorIBA 11/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2023
1	VaccinesIBA 01/2023
1	bicalutamide (Casodex)FDA LinkGeneric 01/2023
1	Triptorelin Pamoate (Trelstar)FDA Link 01/2023
1	AndrogensIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2023
1	CytokinesIBA 11/2022
1	Vascular Endothelial Growth Factor CIBA 11/2022
1	CateninsIBA 02/2022
1	IA 4IBA 11/2021
1	Mechanistic Target of Rapamycin Complex 2IBA 10/2021
1	TOR Serine-Threonine KinasesIBA 10/2021
1	Glycoproteins (Glycoprotein)IBA 09/2021
1	Phosphotransferases (Kinase)IBA 07/2021
1	Imatinib Mesylate (Gleevec)FDA Link 05/2021
1	Tyrosine Kinase InhibitorsIBA 05/2021

Therapy/Procedure

42	Therapeutics 05/2023 - 07/2003
21	Immunotherapy 01/2024 - 04/2015
8	Transplantation 11/2021 - 07/2002
4	Organ Transplantation 01/2022 - 10/2008
4	Drug Therapy (Chemotherapy) 04/2019 - 10/2013
3	Intravenous Infusions 01/2018 - 01/2017
2	Duration of Therapy 01/2019 - 01/2018
2	Kidney Transplantation 11/2017 - 04/2017
2	Precision Medicine 12/2014 - 09/2014
1	Molecular Targeted Therapy 12/2023
1	Aftercare (After-Treatment) 11/2022
1	Neoadjuvant Therapy 05/2021